Dr. Nicolaos Jay Palaskas, MD

Dr. Palaskas practices at UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health.

Dr. Palaskas' NPI, 1750545448, was assigned on July 11, 2008. Dr. Palaskas graduated from Aristotle University of Thessaloniki School of Medicine in 2004. Dr. Palaskas holds California license A114683.

Dr. Palaskas' primary practice is UCLA Santa Monica Medical Center, at 1250 16th Street, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 319-4000.

Dr. Palaskas' primary practice is UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health. Dr. Palaskas is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Palaskas to 1 more group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Palaskas practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Palaskas' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Palaskas is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Palaskas' licenses on file in 2 states: California and Massachusetts.

Dmand AI lists breast cancer, chronic anemia, multiple myeloma, neutropenia, prostate cancer and purpura and thrombocytopenia among the conditions Dr. Palaskas treats.

CMS data shows 1,404 Medicare services from Dr. Palaskas across 16 procedure codes in 2024, for 329 Medicare patients. Medicare paid $99,292 for them.

CMS counts 329 Medicare patients who saw Dr. Palaskas in 2024. The largest group is 65 to 74, with 143 patients. 73% of them have high cholesterol, and 70% have cancer. 15% are also on Medicaid. Their average risk score is 2.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Palaskas' median patient age at 65, with 47% women.

In 2024, Dr. Palaskas wrote 481 Medicare Part D claims for 68 patients. 92% of them were for generic drugs. CMS names the drug for 347 of them, across 9 drugs with 11 or more claims each, at $108,191 in total drug cost. In 2023, CMS named 84 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Palaskas for performance year 2024, reported as part of a group. Dr. Palaskas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Palaskas as offering telehealth.

Dmand AI links 12 papers to Dr. Palaskas, published from 2011 to 2023. 2017 was the busiest year, with 2. The most frequent topics are Drug Resistance, Neoplasm, Signal Transduction and Cell Line, Tumor. Dr. Palaskas has published most often in Cancer Discov. Dr. Palaskas' most frequent co-authors are Ingo K. Mellinghoff, MD, Cameron W. Brennan, MD and Alexandra Drakaki, MD.

CMS Open Payments shows 10 general payments to Dr. Palaskas from 7 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 95% of the total. Janssen Pharmaceuticals, Inc paid the most, $251.

Dr. Palaskas graduated from Aristotle University of Thessaloniki School of Medicine in 2004.

Dr. Palaskas is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.